Cargando…

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

INTRODUCTION: Current evidence on the association between COVID-19 and dementia is sparse. This study aims to investigate the associations between COVID-19 caseload and the burden of dementia. METHODS: We gathered data regarding burden of dementia (disability-adjusted life years [DALYs] per 100,000)...

Descripción completa

Detalles Bibliográficos
Autores principales: Azarpazhooh, M. Reza, Amiri, Amin, Morovatdar, Negar, Steinwender, Sandy, Rezaei Ardani, Amir, Yassi, Nawaf, Biller, Jose, Stranges, Saverio, Tokazebani Belasi, Masoud, Neya, Sepideh Kazemi, Khorram, Bita, Sheikh Andalibi, Mohammad Sobhan, Arsang-Jang, Shahram, Mokhber, Naghmeh, Di Napoli, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334961/
https://www.ncbi.nlm.nih.gov/pubmed/32659508
http://dx.doi.org/10.1016/j.jns.2020.117013
Descripción
Sumario:INTRODUCTION: Current evidence on the association between COVID-19 and dementia is sparse. This study aims to investigate the associations between COVID-19 caseload and the burden of dementia. METHODS: We gathered data regarding burden of dementia (disability-adjusted life years [DALYs] per 100,000), life expectancy, and healthy life expectancy (HALE) from the Global Burden of Disease (GBD) 2017 study. We obtained COVID-19 data from Our World in Data database. We analyzed the association of COVID-19 cases and deaths with the burden of dementia using Spearman's rank correlation coefficient. RESULTS: Globally, we found significant positive (p < .001) correlations between life expectancy (r = 0.60), HALE (r = 0.58), and dementia DALYs (r = 0.46) with COVID-19 caseloads. Likewise, we found similar correlations between life expectancy (r = 0.60), HALE (r = 0.58) and dementia DALYs (r = 0.54) with COVID-19 mortality. CONCLUSION: Health policymakers should clarify a targeted model of disease surveillance in order to reduce the dual burden of dementia and COVID-19.